Vascular Tissue Engineering: Progress, Challenges, and Clinical Promise

Although the clinical demand for bioengineered blood vessels continues to rise, current options for vascular conduits remain limited. The synergistic combination of emerging advances in tissue fabrication and stem cell engineering promises new strategies for engineering autologous blood vessels that...

Full description

Bibliographic Details
Main Authors: Song, H-H Greco (Author), Rumma, Rowza T. (Author), Edelman, Elazer R (Author)
Other Authors: Massachusetts Institute of Technology. Institute for Medical Engineering & Science (Contributor)
Format: Article
Language:English
Published: Elsevier BV, 2020-08-13T13:14:21Z.
Subjects:
Online Access:Get fulltext
LEADER 01720 am a22001933u 4500
001 126550
042 |a dc 
100 1 0 |a Song, H-H Greco  |e author 
100 1 0 |a Massachusetts Institute of Technology. Institute for Medical Engineering & Science  |e contributor 
700 1 0 |a Rumma, Rowza T.  |e author 
700 1 0 |a Edelman, Elazer R  |e author 
245 0 0 |a Vascular Tissue Engineering: Progress, Challenges, and Clinical Promise 
260 |b Elsevier BV,   |c 2020-08-13T13:14:21Z. 
856 |z Get fulltext  |u https://hdl.handle.net/1721.1/126550 
520 |a Although the clinical demand for bioengineered blood vessels continues to rise, current options for vascular conduits remain limited. The synergistic combination of emerging advances in tissue fabrication and stem cell engineering promises new strategies for engineering autologous blood vessels that recapitulate not only the mechanical properties of native vessels but also their biological function. Here we explore recent bioengineering advances in creating functional blood macro and microvessels, particularly featuring stem cells as a seed source. We also highlight progress in integrating engineered vascular tissues with the host after implantation as well as the exciting pre-clinical and clinical applications of this technology. Song et al. explore recent bioengineering advances in creating functional blood macro- and microvessels, particularly featuring stem cells as a seed source. They highlight progress in integrating engineered vascular tissues with the host after implantation as well as the exciting pre-clinical and clinical applications of this technology. 
546 |a en 
655 7 |a Article 
773 |t 10.1016/J.STEM.2018.02.009 
773 |t Cell stem cell